# Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer

> **NCT04350021** · — · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer Metastatic
- Chemotherapy Effect

## Interventions

- **DRUG:** Capecitabine, Cyclophosphamide

## Key facts

- **NCT ID:** NCT04350021
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04350021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04350021, "Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04350021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*